These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 35416703

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of a KPC-84 harboring Klebsiella pneumoniae ST11 clinical isolate with ceftazidime-avibactam resistance.
    Gong Y, Feng Y, Zong Z, Lv X.
    Eur J Clin Microbiol Infect Dis; 2024 Oct; 43(10):2029-2035. PubMed ID: 39110337
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis.
    Shen S, Tang C, Yang W, Ding L, Han R, Shi Q, Guo Y, Yin D, Hu F.
    Emerg Microbes Infect; 2024 Dec; 13(1):2356146. PubMed ID: 38743401
    [Abstract] [Full Text] [Related]

  • 11. In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam.
    Guzmán-Puche J, Pérez-Nadales E, Pérez-Vázquez M, Causse M, Gracia-Ahufinger I, Mendez-Natera A, Allalou-Ruiz Y, Elías C, Oteo-Iglesias J, Torre-Cisneros J, Martínez-Martínez L.
    Int J Antimicrob Agents; 2022 Feb; 59(2):106524. PubMed ID: 35038557
    [Abstract] [Full Text] [Related]

  • 12. KPC-Mediated Resistance to Ceftazidime-Avibactam and Collateral Effects in Klebsiella pneumoniae.
    Findlay J, Poirel L, Juhas M, Nordmann P.
    Antimicrob Agents Chemother; 2021 Aug 17; 65(9):e0089021. PubMed ID: 34228551
    [Abstract] [Full Text] [Related]

  • 13. Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient.
    Zhou J, Yan G, Tang C, Liu J, Fu P, Ding L, Yang W, Guo Y, Wang C, Lu G, Hu F.
    Int J Antimicrob Agents; 2024 Jun 17; 63(6):107163. PubMed ID: 38570018
    [Abstract] [Full Text] [Related]

  • 14. Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
    Di Pilato V, Principe L, Andriani L, Aiezza N, Coppi M, Ricci S, Giani T, Luzzaro F, Rossolini GM.
    Clin Microbiol Infect; 2023 Apr 17; 29(4):537.e1-537.e8. PubMed ID: 36414199
    [Abstract] [Full Text] [Related]

  • 15. Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam.
    Shen S, Tang C, Ding L, Han R, Yin D, Yang W, Guo Y, Hu F.
    mSphere; 2022 Dec 21; 7(6):e0048722. PubMed ID: 36374086
    [Abstract] [Full Text] [Related]

  • 16. Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.
    Hobson CA, Pierrat G, Tenaillon O, Bonacorsi S, Bercot B, Jaouen E, Jacquier H, Birgy A.
    Antimicrob Agents Chemother; 2022 Sep 20; 66(9):e0044722. PubMed ID: 35980232
    [Abstract] [Full Text] [Related]

  • 17. First report of KPC variants conferring ceftazidime-avibactam resistance in Colombia: introducing KPC-197.
    De la Cadena E, Mojica MF, Rojas LJ, Castro BE, García-Betancur JC, Marshall SH, Restrepo N, Castro-Caro NP, Fonseca-Carrillo M, Pallares C, Bonomo RA, Villegas MV.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0410523. PubMed ID: 38700337
    [Abstract] [Full Text] [Related]

  • 18. Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering.
    Barnes MD, Winkler ML, Taracila MA, Page MG, Desarbre E, Kreiswirth BN, Shields RK, Nguyen MH, Clancy C, Spellberg B, Papp-Wallace KM, Bonomo RA.
    mBio; 2017 Oct 31; 8(5):. PubMed ID: 29089425
    [Abstract] [Full Text] [Related]

  • 19. Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene.
    Antinori E, Unali I, Bertoncelli A, Mazzariol A.
    Clin Microbiol Infect; 2020 Jul 31; 26(7):946.e1-946.e3. PubMed ID: 32061796
    [Abstract] [Full Text] [Related]

  • 20. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant Klebsiella pneumoniae.
    Wu Y, Yu W, Chu X, Zhang J, Jia P, Liu X, Zhu Y, Xu Y, Yang Q.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0010724. PubMed ID: 38712934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.